Role for peroxisome proliferator-activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 interleukin-8 by endothelial cells

Circulation Research

Volumn 87, Issue 6, 2000, Pages 516-521

  Lee, Hans ^a   Shi, Weibin ^a   Tontonoz, Peter ^b,c   Wang, Shirley ^a   Subbanagounder, Ganesamoorthy ^a   Hedrick, Catherine C ^f   Hama, Susan ^a   Borromeo, Christine ^a   Evans, Ronald M ^c,d   Berliner, Judith A ^a,b   Nagy, Laszlo ^c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f NONE

Author keywords

Atherosclerosis; Endothelium; Interleukins; Lipoproteins; Monocyte chemotactic protein 1; Phospholipids

Indexed keywords

INTERLEUKIN 8; LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPID; PIRINIXIC ACID; TRANSCRIPTION FACTOR; TROGLITAZONE;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA RESPONSIVE ELEMENT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIGAND BINDING; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR DENSITY;

EID: 0034665060     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.6.516     Document Type: Article

References (38)

1. Atherosclerosis: Basic mechanisms: Oxidation, inflammation, and genetics
2. The role of oxidized lipoproteins in atherogenesis
3. Control of leukocyte adhesion and activation in atherogenesis
4. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
5. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein
6. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils
7. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate
8. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
9. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
10. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
11. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferator-activated receptor α
12. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein
13. Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
14. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: Evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism
15. Modification of the Recalde method for the isolation of human monocytes
16. Determination of lipid ester ozonides and core aldehydes by high-performance liquid chromatography with on-line mass spectrometry
17. A novel method for real time quantitative RT-PCR
18. 2 is a ligand for the adipocyte determination factor PPARγ
19. A vector for expressing GAL4(1-147) fusions in mammalian cells
20. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
21. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
22. A simple and sensitive method for monitoring drug-induced cell injury in cultured cells
23. Roles of multiple oxidized LDL lipids in cellular injury: Dominance of 7 β-hydroperoxycholesterol
24. Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cells
25. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction
26. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
27. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling
28. PPARγ is required for placental, cardiac, and adipose tissue development
29. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
30. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL
31. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor γ: Implications for cardiovascular disease
32. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
33. Induction of monocyte binding to endothelial cells by MM-LDL: Role of lipoxygenase metabolites
34. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
35. Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging
36. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
37. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
38. Determinants of the bioactivity of oxidized phospholipids: Specific oxidized fatty acyl groups at the sn-2 position